Found: 9
Select item for more details and to access through your institution.
Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1058424
- By:
- Publication type:
- Article
Identification of 18 F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer.
- Published in:
- Nutrients, 2023, v. 15, n. 13, p. 3042, doi. 10.3390/nu15133042
- By:
- Publication type:
- Article
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27).
- Published in:
- 2020
- By:
- Publication type:
- journal article
SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization.
- Published in:
- Nature Communications, 2016, v. 7, n. 12, p. 13875, doi. 10.1038/ncomms13875
- By:
- Publication type:
- Article
Bone metastases in gastrointestinal cancer.
- Published in:
- Clinical & Experimental Metastasis, 2015, v. 32, n. 1, p. 7, doi. 10.1007/s10585-014-9686-x
- By:
- Publication type:
- Article
Consore: A Powerful Federated Data Mining Tool Driving a French Research Network to Accelerate Cancer Research.
- Published in:
- International Journal of Environmental Research & Public Health, 2024, v. 21, n. 2, p. 189, doi. 10.3390/ijerph21020189
- By:
- Publication type:
- Article
Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 10, p. 2299, doi. 10.1002/ijc.30290
- By:
- Publication type:
- Article
Sorafenib alone vs. sorafenib plus GEMOX as 1<sup>st</sup>-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial.
- Published in:
- British Journal of Cancer, 2019, v. 120, n. 9, p. 896, doi. 10.1038/s41416-019-0443-4
- By:
- Publication type:
- Article
Sorafenib alone vs. sorafenib plus GEMOX as 1<sup>st</sup>-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article